Gycabiane and Glycemic Control of Prediabetic Subjects
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01530685 |
Recruitment Status : Unknown
Verified February 2012 by Pileje.
Recruitment status was: Recruiting
First Posted : February 10, 2012
Last Update Posted : February 10, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hyperglycemia | Dietary Supplement: Glycabiane Dietary Supplement: placebo | Phase 3 |
Cinnamon's effects on blood glucose have been the subject of many clinical and animal studies; however, the issue of cinnamon intake's effect on fasting blood glucose (FBG) in people with prediabetes still remains unclear.
The main purpose of this study is to examine the effects of supplementation with Glycabiane, a dietary supplement rich in cinnamon extract, on fast blood glucose of overweight prediabetic subjects in a randomized, placebo-controlled, clinical trial.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Treatment |
Official Title: | Effect of Glycabiane, a Dietary Supplement, on Glycemic Control of Prediabetic Subjects |
Study Start Date : | November 2011 |
Estimated Primary Completion Date : | April 2012 |
Estimated Study Completion Date : | August 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: Glycabiane, gelule |
Dietary Supplement: Glycabiane
2 gelule per day for 4 months
Other Name: Dietary supplement |
Placebo Comparator: Placebo |
Dietary Supplement: placebo
2 gelules per day for 4 months |
- Fast Blood Glucose [ Time Frame: 4 months ]Fast blood glucose will be measured before and after 4 months of supplementation and after 2 months of wash-out

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 25 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Male or female from 25 to 65 years old
- 1.0g/L ≤ fast blood glucose < 1.26g/L
- overweight (IMC > 25)
Exclusion Criteria:
- thyroid disease
- hypogonadism
- History of musculoskeletal, autoimmune or neurological disease
- Treatment against thyroid disease, hypoglycemia, hypertension, or anti-coagulant
- Pregnant or lactating women

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01530685
Contact: Karine Clément, Pr | +33 1 42 17 79 19 | karine.clement@psl.aphp.fr |
France | |
CHU Pitié Salpetriere | Recruiting |
Paris, France, 75013 | |
Contact: Salwa Rizkalla, Dr +33 1 42 17 79 81 salwa.rizkalla@psl.aphp.fr |
Principal Investigator: | Karine Clément, MD | INSERM U872 |
Responsible Party: | Pileje |
ClinicalTrials.gov Identifier: | NCT01530685 |
Other Study ID Numbers: |
PILEJE-Glyca-0910 |
First Posted: | February 10, 2012 Key Record Dates |
Last Update Posted: | February 10, 2012 |
Last Verified: | February 2012 |
cinnamon chromium prediabete overweight |
Hyperglycemia Glucose Metabolism Disorders Metabolic Diseases |